APA (7th ed.) Citation

Yuwei Jiang, Jiaoya Xu, Ping Huang, Lili Yang, Yang Liu, Yiping Li, . . . Peiyong Zheng. (2022). Scoparone Improves Nonalcoholic Steatohepatitis Through Alleviating JNK/Sab Signaling Pathway-Mediated Mitochondrial Dysfunction. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Yuwei Jiang, Jiaoya Xu, Ping Huang, Lili Yang, Yang Liu, Yiping Li, Jue Wang, Haiyan Song, and Peiyong Zheng. Scoparone Improves Nonalcoholic Steatohepatitis Through Alleviating JNK/Sab Signaling Pathway-Mediated Mitochondrial Dysfunction. Frontiers Media S.A., 2022.

MLA (9th ed.) Citation

Yuwei Jiang, et al. Scoparone Improves Nonalcoholic Steatohepatitis Through Alleviating JNK/Sab Signaling Pathway-Mediated Mitochondrial Dysfunction. Frontiers Media S.A., 2022.